ECKERT & ZIEGLER SE |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.1 EUR | -0.54% |
|
-3.90% | -19.95% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Sector
Office Equipment
Calendar
2024-05-14
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
33.28
EUR
Average target price
60
EUR
Spread / Average Target
+80.29%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.95% | 739M | |
| +4.11% | 7.99B | |
| -3.90% | 4.52B | |
| -11.93% | 2.77B | |
| +3.17% | 2.26B | |
| -27.93% | 1.1B | |
| -7.90% | 804M | |
| -32.24% | 666M | |
| -58.43% | 658M | |
| -29.64% | 627M |
- Stock Market
- Equities
- EUZ Stock
- News Eckert & Ziegler SE
- Eckert & Ziegler Unit Enters Supply Deal for Ytterbium-176 Isotope with US Firm; Shares Down 5%
